Existing medicines for heart failure aim to modify the workload of the heart primarily, instead of promote ventricular repair. Acorda submitted an IND for GGF2 as a therapy for heart failure, predicated on extensive research by the ongoing firm and both independent and collaborative academic centers. Acorda is also continuing preclinical studies of potential neurology indications for GGF2 and other neuregulin growth factors.. Acorda Therapeutics to initiate Phase 1 clinical trial of GGF2 for heart failure in mid-2010 Acorda Therapeutics, Inc. today announced programs to initiate a Phase 1 single-dose scientific trial of the business’s compound, Glial Growth Factor 2 , in individuals with heart failing in mid-2010, based on an IND filed with the U.S.But, it has no impact on the data that is being measured usually. Accurate outcomes of polysomnography generally don’t necessitate a proper sleep during the night. Also, you can begin your normal morning hours routine immediately after the polysomnography. Risks of Polysomnography Polysomnogram test is risk-free and a painless procedure. You might experience small itching on your epidermis from the adhesive that stay the sensors on your body. However, the itching is temporary and may last just for a couple of minutes or so. Finding your way through Polysomnography Before taking the Polysomnogram test, your doctor may ask you to avoid drinking alcohol or consuming caffeine.